Abrogated cardio protective effect of ischemic preconditioning in hyperhomocysteinemia and hypertrophy Shaiba Sana Qureshi, Ahsas Goyal Journal of Indian College of Cardiology Volume 6, Issue 2, Pages 53-58 (June 2016) DOI: 10.1016/j.jicc.2016.06.007 Copyright © 2016 Indian College of Cardiology Terms and Conditions
Fig. 1 Molecular mechanism of ischemia preconditioning. Journal of Indian College of Cardiology 2016 6, 53-58DOI: (10.1016/j.jicc.2016.06.007) Copyright © 2016 Indian College of Cardiology Terms and Conditions
Fig. 2 Pathways involved in abrogated cardioprotection in hyperhomocysteinemia. JAK 2: Janus kinase 2; Akt: protein kinase B. Journal of Indian College of Cardiology 2016 6, 53-58DOI: (10.1016/j.jicc.2016.06.007) Copyright © 2016 Indian College of Cardiology Terms and Conditions
Fig. 3 Pathways involved in abolition of IPC cardioprotection in Hypertrophied heart. NFAT: nuclear factor activated T cells; NF: nuclear factor. Journal of Indian College of Cardiology 2016 6, 53-58DOI: (10.1016/j.jicc.2016.06.007) Copyright © 2016 Indian College of Cardiology Terms and Conditions